Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemo-proteomics exploration of HDAC degradability by small molecule degraders
Yuan Xiong, Katherine A. Donovan, Nicholas A. Eleuteri, et al.
Cell chemical biology (2021) Vol. 28, Iss. 10, pp. 1514-1527.e4
Open Access | Times Cited: 67

Showing 26-50 of 67 citing articles:

Discovery of Selective Proteolysis-Targeting Chimera Degraders Targeting PTP1B as Long-Term Hypoglycemic Agents
Zunhua Yang, Yuqi Ying, Shaobing Cheng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7569-7584
Closed Access | Times Cited: 5
Designing HDAC-PROTACs: Lessons Learned So Far
Fabian Fischer, Leandro A. Alves Avelar, Laoise Murray, et al.
Future Medicinal Chemistry (2021) Vol. 14, Iss. 3, pp. 143-166
Open Access | Times Cited: 29
Chemically induced degradation of epigenetic targets
Md Kabir, Xufen Yu, H. Ümit Kanıskan, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 13, pp. 4313-4342
Open Access | Times Cited: 13
The application of PROTAC in HDAC
Shaoting Chen, Yuxiang Zheng, Benji Liang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115746-115746
Closed Access | Times Cited: 12
Histone modifications and their roles in macrophage-mediated inflammation: a new target for diabetic wound healing
Jing Wang, Jiawei Feng, Yiming Ni, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Targeted Protein Degradation: Design Considerations for PROTAC Development
Nathan L. Tran, Georges A. Leconte, Fleur M. Ferguson
Current Protocols (2022) Vol. 2, Iss. 12
Open Access | Times Cited: 18
Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects
Jinxiao Ru, Yuxi Wang, Zijia Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115800-115800
Closed Access | Times Cited: 10
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
Yuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Development of Ethyl-Hydrazide-Based Selective Histone Deacetylase 6 (HDAC6) PROTACs
Daniel Stopper, Irina Honin, Felix Feller, et al.
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 3, pp. 487-495
Closed Access
A ‘click’ chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras
Jasmine M. Cross, Megan E. Coulson, Joshua P. Smalley, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 12, pp. 1634-1639
Open Access | Times Cited: 16
Distinct biochemical properties of the class I histone deacetylase complexes
Kwangwoon Lee, Samuel D. Whedon, Zhipeng A. Wang, et al.
Current Opinion in Chemical Biology (2022) Vol. 70, pp. 102179-102179
Open Access | Times Cited: 15
PROTAC chemical probes for histone deacetylase enzymes
Urvashi Patel, Joshua P. Smalley, James T. Hodgkinson
RSC Chemical Biology (2023) Vol. 4, Iss. 9, pp. 623-634
Open Access | Times Cited: 9
Histone deacetylase 10: A polyamine deacetylase from the crystal structure to the first inhibitors
Chiara Lambona, Clemens Zwergel, Rossella Fioravanti, et al.
Current Opinion in Structural Biology (2023) Vol. 82, pp. 102668-102668
Open Access | Times Cited: 9
PROTAC‐Mediated HDAC7 Protein Degradation Unveils Its Deacetylase‐Independent Proinflammatory Function in Macrophages
Kailibinuer Kadier, Tian Niu, Baoli Ding, et al.
Advanced Science (2024)
Open Access | Times Cited: 3
Extrapolating Lessons from Targeted Protein Degradation to Other Proximity-Inducing Drugs
Georg E. Winter
ACS Chemical Biology (2024)
Open Access | Times Cited: 3
Exploring the landscape of post-translational modification in drug discovery
Yuhao Cao, Tianyi Yu, Zhiguang Zhu, et al.
Pharmacology & Therapeutics (2024) Vol. 265, pp. 108749-108749
Closed Access | Times Cited: 3
Recent progress on small molecules targeting epigenetic complexes
Yukihiro Itoh, Yuri Takada, Yasunobu Yamashita, et al.
Current Opinion in Chemical Biology (2022) Vol. 67, pp. 102130-102130
Closed Access | Times Cited: 13
Epigenetic control of pancreatic cancer metastasis
Lukas Krauß, Carolin Schneider, Elisabeth Heßmann, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 4, pp. 1113-1131
Open Access | Times Cited: 7
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
Gongwei Wu, Noriaki Yoshida, Jihe Liu, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 714
Open Access | Times Cited: 6
Proteomics‐Based Discovery of First‐in‐Class Chemical Probes for Programmed Cell Death Protein 2 (PDCD2)
Wenzhi Ji, Woong Sub Byun, Wenchao Lu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 43
Closed Access | Times Cited: 4
Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues
Marta Pichlak, Tomasz Sobierajski, K. M. Błażewska, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
Chemical immunology: Recent advances in tool development and applications
Yujie Shi, Eleanor E. Bashian, Yingqin Hou, et al.
Cell chemical biology (2024) Vol. 31, Iss. 3, pp. 387-408
Open Access | Times Cited: 1
Machine learning modeling of protein-intrinsic features predicts tractability of targeted protein degradation
Wubing Zhang, Shourya S. Roy Burman, Jiaye Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
PROTAC Degraders
Alessio Ciulli, Oliver Hsia
(2022), pp. 317-356
Closed Access | Times Cited: 3
HDAC6/aggresome processing pathway importance for inflammasome formation is context dependent
Longlong Wang, Adeline Unterreiner, Ronan Kapétanovic, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Scroll to top